MALIGNANT SOLID TUMORS
Clinical trials for MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection SHR-4298 enters early trials for Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new drug called SHR-4298 in about 200 adults with advanced solid tumors that have spread or come back. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors or slow cancer growth. Participants will receive the drug by inj…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New combo therapy aims to shrink hard-to-treat tumors
Disease control Not yet recruitingThis study tests a new drug, JCXH-211, injected directly into tumors along with an anti-PD-1 antibody given through a vein. It is for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and tolerable…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC